McDonald Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-21,175
Closed -$789K 224
2022
Q2
$789K Buy
21,175
+226
+1% +$9.2K 0.2% 137
2022
Q1
$928K Buy
+20,949
New +$908K 0.2% 134
2021
Q4
Sell
-16,418
Closed -$712K 569
2021
Q3
$712K Sell
16,418
-488
-3% -$21.6K 0.17% 157
2021
Q2
$723K Buy
16,906
+4,284
+34% +$180K 0.17% 147
2021
Q1
$488K Buy
12,622
+5,654
+81% +$214K 0.13% 174
2020
Q4
$250K Buy
+6,968
New +$251K 0.07% 242

Other funds holding BSX

McDonald Partners's BSX Position: Q3 2022 in Review

McDonald Partners sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 21,175 shares — an estimated $789K sold.

McDonald Partners first reported a position in BSX in Q4 2020 and held it in 6 quarters. The position peaked at $928K in Q1 2022. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • McDonald Partners reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
  • McDonald Partners sold 21,175 Boston Scientific shares in Q3 2022, an estimated $789K.
  • McDonald Partners first reported a position in Boston Scientific in Q4 2020 and held it in 6 quarters.
  • McDonald Partners's Boston Scientific position peaked at $928K in Q1 2022.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on McDonald Partners's 13F filing for Q3 2022, filed 21 Oct 2022.